Rajan Saggar, MD
Professor of Medicine & Director, Pulmonary Hypertension Program
David Geffen School of Medicine, UCLA
Los Angeles, CA, United States
Disclosure information not submitted.
Kristin Highland, MD
Director, Rheumatic Lung Disease Program
Cleveland Clinic
Shaker Heights, OH, United States
Disclosure information not submitted.
Dinesh Khanna, MD, MSc
University of Michigan
Ann Arbor, MI, United States
Disclosure information not submitted.
Chad Miller, MD
Medical Director, Pulmonary Hypertension
Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead
Atlanta, GA, United States
Disclosure information not submitted.
Anjali Vaidya, MD, FACC, FASE, FACP
Co-Director, Pulmonary Hypertension, Right Heart Failure, and CTEPH Program
Temple University Lewis Katz School of Medicine
Philadelphia, PA, United States
Disclosure information not submitted.
Patients with connective tissue disease (CTD), especially systemic sclerosis (SSc) or scleroderma spectrum disorders, are at significantly higher risk than other patients for developing pulmonary arterial hypertension (PAH). The big question revolves around discovering latent PAH in the connective disease patient, particularly the SSc group. The live court case will explore the central question of whether all patients seen in a rheumatology practice should receive a screening echocardiogram. This pro/con debate will place you, the audience, in the role of the juror to decide the outcome. Evidence is presented, and expert witnesses queried on the pluses and minuses of universal, routine screening echocardiograms in rheumatology patients.
Developed by Global Learning Collaborative and supported by an educational grant from Janssen/Actelion Pharmaceuticals US.
Global Learning Collaborative (GLC) designates this activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Global Learning Collaborative (GLC) designates this activity for 1.5 hours of Nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity. Global Learning Collaborative (GLC) designates this activity for 1.5 contact hour/0.15 CEUs of Pharmacy contact hours.
